Galapagos And Gilead Collaborate On Ouro's $1.675B Acquisition, Retaining $500M Cash With Up To $150M Return To Shareholders

New collaboration structure achieves meaningfully improved financial terms and flexibility for Galapagos 

Following this transaction, the Company will continue to have a majority of its cash remaining for additional strategic transactions and other capital allocation priorities

Opportunity to develop a potential first-in-class & best-in-class T cell engager in autoimmune diseases with gamgertamig